Category: White House
-
Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency
Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency WASHINGTON — Vinay Prasad, a top official at the Food and Drug Administration who has been at the center of recurring public controversies, is exiting the agency for a second time. Prasad will leave the FDA at the…
-
STAT+: Trump most-favored nation drug pricing deals end after three years for some companies
STAT+: Trump most-favored nation drug pricing deals end after three years for some companies WASHINGTON — President Trump often brags that the “most-favored nation” deals he struck with drugmakers have set the country on a new path to no longer paying more than its fair share for prescription drug costs. But many details of the…
-
Opinion: Former surgeon general: The Senate must not approve someone who can’t practice medicine as the nation’s top doctor
Opinion: Former surgeon general: The Senate must not approve someone who can’t practice medicine as the nation’s top doctor Eight years ago, I sat before the Senate for my confirmation hearing to be surgeon general. Republican Todd Young (Ind.) and Democrat Joe Donnelly (Ind.) introduced me, and I was confirmed unanimously. That bipartisan support reflected…
-
STAT+: Exit of CDC’s acting director highlights agency’s lack of leader
STAT+: Exit of CDC’s acting director highlights agency’s lack of leader For 28 days last summer, the Centers for Disease Control and Prevention had a director who had been confirmed by the Senate. But in less time than it took Susan Monarez to get approved, she was fired for not kowtowing to her boss, Robert…
-
Major shakeup underway at HHS as White House braces for midterms
Major shakeup underway at HHS as White House braces for midterms WASHINGTON — Two top health officials are leaving their jobs amid a shakeup at the Department of Health and Human Services aimed at refocusing HHS on politically popular aspects of health secretary Robert F. Kennedy Jr.’s agenda in advance of the midterm elections. Deputy…
-
STAT+: TrumpRx claims to offer the lowest prices. But many drugs have cheaper generics
STAT+: TrumpRx claims to offer the lowest prices. But many drugs have cheaper generics WASHINGTON — President Trump said the administration’s new TrumpRx website will offer the cheapest prices in the world for 43 brand-name drugs, and counting. But about half of them are already available as generics, usually for much less. The website is…
-
STAT+: White House looks for more drug pricing deals to add to TrumpRx
STAT+: White House looks for more drug pricing deals to add to TrumpRx WASHINGTON — After striking 16 deals with pharmaceutical giants and launching a direct-to-consumer drug purchasing platform, the Trump administration is looking to expand its efforts to lower drug prices to more companies. Federal officials on Thursday unveiled the administration’s TrumpRx drug purchasing…
-
Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s
Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s On this week’s episode of The Readout LOUD: two starkly different financial outlooks from Novo Nordisk and Eli Lilly, a psychedelics drug from Compass Pathways encountered a roadblock with the Trump White House, and a closer look at why manufacturing problems have slowed…
-
What to know about TrumpRx, the Trump administration’s prescription drug platform
What to know about TrumpRx, the Trump administration’s prescription drug platform President Trump on Thursday night is planning to announce the launch of TrumpRx, the website that he and his aides have touted for months as a platform aimed at lowering prescription drug prices. The website, which uses technology from health care company GoodRx, is…
-
STAT+: Limit on multiyear funding of NIH grants is a sticking point in Senate budget talks
STAT+: Limit on multiyear funding of NIH grants is a sticking point in Senate budget talks Last year, the country’s biomedical researchers watched with apprehension as the National Institutes of Health’s grant awards lagged billions of dollars behind the pace of previous years. Fears grew that the Trump administration would impound funds appropriated by Congress…
-
STAT+: Trump releases health care plan amid pressure over affordability
STAT+: Trump releases health care plan amid pressure over affordability WASHINGTON — President Trump on Thursday released a hodgepodge of health care policies that would create new price-control power over pharmaceutical companies, but that otherwise wouldn’t fundamentally overhaul America’s existing system, as he faces mounting pressure to address the cost of insurance and care. The…
-
STAT+: The 3 biggest issues to watch in vaccine policy in 2026
STAT+: The 3 biggest issues to watch in vaccine policy in 2026 WASHINGTON — Vaccine policy has become a key issue for the Trump administration, especially under the leadership of health secretary Robert F. Kennedy Jr., who himself once led an anti-vaccine group. In less than a year, Kennedy has bulldozed vaccine policy precedent and…
-
STAT+: More drugmakers set to sign pricing deals with Trump on Friday
STAT+: More drugmakers set to sign pricing deals with Trump on Friday WASHINGTON — Several drugmakers are expected to sign pricing agreements with the Trump administration on Friday, according to four people familiar with the plans, who were not authorized to speak publicly. The agreements would be the latest in a series of deals in…
-
Opinion: The U.S. government’s failure to acknowledge World AIDS Day takes us back to a troubling time
Opinion: The U.S. government’s failure to acknowledge World AIDS Day takes us back to a troubling time “Silence = Death.” That was the mantra of determined AIDS activists who quickly concluded the U.S. government was not doing enough to combat the then-emergent AIDS epidemic, which first hit the headlines in 1981. Read the rest… Gavin…
-
STAT+: Trump weighs plan to extend extra ACA subsidies for two years
STAT+: Trump weighs plan to extend extra ACA subsidies for two years WASHINGTON — In an about-face, the White House is weighing a proposal to extend the Affordable Care Act enhanced subsidies that Democrats have been clamoring for since last year. ACA health insurance enrollees face a spike in premium payments if Congress does not…
-
Federal judge orders Trump administration to fully fund SNAP benefits in November
Federal judge orders Trump administration to fully fund SNAP benefits in November A federal judge in Rhode Island ordered the Trump administration Thursday to find the money to fully fund SNAP benefits for November. The ruling by U.S. District Judge John J. McConnell Jr. gave President Donald Trump’s administration until Friday to make the payments…
-
‘It’s a massacre’: CDC battered by government shutdown firings
‘It’s a massacre’: CDC battered by government shutdown firings WASHINGTON — The White House’s mass firing of Centers for Disease Control and Prevention staff on Friday has decimated offices related to injury prevention, respiratory disease surveillance, and chronic disease, according to four people familiar with the cuts. Overall, the White House is expected to cut…
-
STAT+: Deep cuts made to CDC’s flagship MMWR publication, a cornerstone of public health
STAT+: Deep cuts made to CDC’s flagship MMWR publication, a cornerstone of public health WASHINGTON — Centers for Disease Control and Prevention staff behind the agency’s flagship publication have suffered deep cuts as part of the firings the Health and Human Services Department has blamed on the government shutdown, according to five people familiar with the situation. Almost the…
-
STAT+: AstraZeneca strikes drug pricing deal with Trump
STAT+: AstraZeneca strikes drug pricing deal with Trump WASHINGTON — President Trump on Friday said he struck a drug pricing deal with AstraZeneca aimed at fulfilling his plan to bring U.S. drug prices in line with what other countries pay, the second agreement after Pfizer’s last week. Similar to Pfizer’s deal, the British pharma company…
-
STAT+: Pharma companies scramble to make deals with Trump after Pfizer scored White House praise
STAT+: Pharma companies scramble to make deals with Trump after Pfizer scored White House praise WASHINGTON — The agreement between Pfizer and the Trump administration to lower drug prices has sent other companies scrambling to make a deal. Several major pharmaceutical firms that received letters from President Trump demanding lower prices have been hustling to…
-
STAT+: Trump administration backs off 100% pharma tariffs threatened to start today
STAT+: Trump administration backs off 100% pharma tariffs threatened to start today WASHINGTON — President Trump told pharmaceutical companies last week that they should start building infrastructure in the U.S. — or face a 100% tariff, starting Wednesday. But a White House official told STAT on Wednesday that the tariffs have not gone into effect…
-
Trump strikes deal with Pfizer aimed at lowering prescription drug prices
Trump strikes deal with Pfizer aimed at lowering prescription drug prices WASHINGTON — President Trump announced on Tuesday that Pfizer has agreed to offer lower prices on its drugs to the Medicaid program and directly to patients, the first in what he said would be a series of deals intended to secure cheaper prescription medicines…
-
STAT+: With Trump’s anti-vaccine comments, Kennedy’s influence grows
STAT+: With Trump’s anti-vaccine comments, Kennedy’s influence grows WASHINGTON — President Trump’s anti-vaccine comments on Monday signal health secretary Robert F. Kennedy Jr.’s growing influence — and raise new questions about how far the pair may go to upend vaccine policy. Standing with Kennedy beside him at the White House, Trump called the childhood vaccine…
-
STAT+: Surgeon general nominee Casey Means discloses financial ties to supplement industry
STAT+: Surgeon general nominee Casey Means discloses financial ties to supplement industry WASHINGTON — New financial disclosures from surgeon general nominee Casey Means show that she’s made hundreds of thousands of dollars promoting supplements and other health and wellness products, details likely to invite new scrutiny about potential conflicts of interest for the author and…
-
STAT+: Hill staff gets briefed on implications of Trump’s drug pricing plan
STAT+: Hill staff gets briefed on implications of Trump’s drug pricing plan WASHINGTON — Congress is again discussing the Trump administration’s plan to force drug companies to lower their U.S. prices, at least behind the scenes. Congressional staffers and health policy experts from major think tanks held a closed-door meeting to discuss policy options that…
-
STAT+: Harvard federal funding set to resume — at least for now
STAT+: Harvard federal funding set to resume — at least for now Federal agencies have begun to inform Harvard that it is in the process of restoring at least some of its previously canceled research funding. The notices come a week after a federal judge in Boston said the Trump administration illegally canceled nearly $3…
-
STAT+: Amid chaos at CDC, Kennedy consolidates his power
STAT+: Amid chaos at CDC, Kennedy consolidates his power WASHINGTON — In another administration, an exodus of top public health officials would’ve been an earth-shattering crisis for the head of the Department of Health and Human Services. In the age of MAHA, it seems like just another week under Secretary Robert F. Kennedy Jr. If…
-
Trump’s hand bruise renews attention to his health — and his heart
Trump’s hand bruise renews attention to his health — and his heart President Trump’s bruised hand and his apparent use of makeup to cover the discolored patch of skin have renewed attention to his health in general and his cardiovascular health in particular. His case also highlights an often underrecognized and undertreated condition. It’s called…
-
STAT+: Trump executive order seeks to centralize control of grantmaking under political appointees
STAT+: Trump executive order seeks to centralize control of grantmaking under political appointees A sweeping new executive order seeks to transform how the federal government awards billions of dollars in research grants by giving President Trump’s political appointees unprecedented power over the projects agencies fund. The order issued Thursday night, titled “Improving Oversight Of Federal…
-
STAT+: Health care and tech companies promise CMS they’ll make patient data more accessible
STAT+: Health care and tech companies promise CMS they’ll make patient data more accessible On Wednesday, over 60 health tech companies signed a pledge orchestrated by the Centers for Medicare and Medicaid Services to make health data-sharing easier and to build apps for patients to access and act on their health data. CMS Administrator Mehmet…
-
STAT+: Top White House pandemic preparedness official resigns, officials say, in sign of broader disarray
STAT+: Top White House pandemic preparedness official resigns, officials say, in sign of broader disarray When reports circulated in February that the White House had selected biosecurity expert Gerald Parker as the head of its Office of Pandemic Preparedness and Response Policy, there was palpable relief among infectious disease experts. As former commander of the…
-
U.S. drops charges against doctor accused of throwing away Covid shots, selling fake vaccine cards
U.S. drops charges against doctor accused of throwing away Covid shots, selling fake vaccine cards The federal government on Saturday dismissed charges against a Utah plastic surgeon accused of throwing away COVID-19 vaccines, giving children saline shots instead of the vaccine and selling faked vaccination cards. U.S. Attorney General Pam Bondi said in a post on the social…
-
STAT+: Dr. Oz tries to seal the deal on Trump’s tax-cut bill
STAT+: Dr. Oz tries to seal the deal on Trump’s tax-cut bill WASHINGTON — As GOP leadership pushes to pass President Trump’s tax megabill this week, one administration official has been working hard behind the scenes to close the deal: Mehmet Oz, who oversees Medicare and Medicaid. House Republicans, including those on the fence about…
-
STAT+: Trump administration demands pharma companies begin drug price negotiations, a day after key deadline
STAT+: Trump administration demands pharma companies begin drug price negotiations, a day after key deadline WASHINGTON — The Trump administration is pushing pharmaceutical companies to begin negotiations to bring their drug prices in line with what other countries pay — usually far less than Americans. “Under President Trump’s direction, HHS is demanding that pharmaceutical companies…
-
White House acknowledges problems in RFK Jr.’s MAHA report
White House acknowledges problems in RFK Jr.’s MAHA report WASHINGTON — The White House will fix errors in a much-anticipated federal government report spearheaded by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., which decried America’s food supply, pesticides and prescription drugs. Kennedy’s wide-ranging “Make America Healthy Again” report, released last week, cited hundreds of…
-
Trump’s science adviser calls for return to ‘gold-standard’ research to kickstart stalled advances
Trump’s science adviser calls for return to ‘gold-standard’ research to kickstart stalled advances President Trump’s science adviser, Michael Kratsios, called for a return to reproducible and transparent research to kickstart what he characterized as years of stalled scientific progress, in his first detailed public remarks on science policy since taking office in March. Kratsios, who…
-
Former President Biden diagnosed with aggressive prostate cancer
Former President Biden diagnosed with aggressive prostate cancer WASHINGTON — Former President Joe Biden has been diagnosed with prostate cancer, his office said Sunday. Biden was seen last week by doctors after urinary symptoms and a prostate nodule was found. He was diagnosed with prostate cancer on Friday, with the cancer cells having spread to…
-
STAT+: Trump nominates Casey Means, entrepreneurial doctor and MAHA leader, for surgeon general
STAT+: Trump nominates Casey Means, entrepreneurial doctor and MAHA leader, for surgeon general The health entrepreneur and “Make America Healthy Again” leader Casey Means has been nominated to be the U.S. surgeon general after President Trump pulled his prior nominee suddenly on Wednesday. Means, an M.D. and author who runs a holistic wellness blog and…
-
White House withdraws nomination of a former Fox News contributor for U.S. surgeon general
White House withdraws nomination of a former Fox News contributor for U.S. surgeon general WASHINGTON — The White House is withdrawing the nomination of former Fox News medical contributor Janette Nesheiwat for U.S. surgeon general, marking at least the second health-related pick from President Donald Trump to be pulled from Senate consideration. The withdrawal was confirmed by two people…
-
STAT+: Trump proposes billions in cuts to federal health agencies from NIH to CDC
STAT+: Trump proposes billions in cuts to federal health agencies from NIH to CDC WASHINGTON — President Trump on Friday proposed massive cuts to the federal government’s health agencies in his 2026 budget request, arguing that Congress should reduce spending by tens of billions from current levels. The request would be a 26% cut to…
-
STAT+: Collins and fellow GOP senators speak out in opposition to Trump’s cuts to biomedical research
STAT+: Collins and fellow GOP senators speak out in opposition to Trump’s cuts to biomedical research WASHINGTON — There was broad bipartisan support at a Senate hearing Wednesday to reverse course on the Trump administration’s cuts to federally funded biomedical research. Sen. Susan Collins (Maine), the Republican chair of the Senate Appropriations Committee, kicked off…
-
White House trumpets Covid lab leak theory on web page that was devoted to health information
White House trumpets Covid lab leak theory on web page that was devoted to health information A government website long used to provide the latest guidelines on managing Covid-19, as well as information on how to receive tests, vaccines and treatments has now been replaced with a page proclaiming the virus emerged from a lab…
-
STAT+: Trump’s new drug policy mixes ‘harshest’ penalties for dealers and test strips for users
STAT+: Trump’s new drug policy mixes ‘harshest’ penalties for dealers and test strips for users The Trump administration vows to emphasize addiction treatment alongside an enforcement-first drug policy, according to a not-yet-public strategy document obtained by STAT. In an effort to reduce overdose deaths caused by fentanyl and other illicit substances, the administration plans to…
-
Trump chooses Fox News contributor Sara Carter as next drug czar
Trump chooses Fox News contributor Sara Carter as next drug czar President Trump has selected Sara Carter, a conservative journalist and Fox News contributor, as the nation’s next drug czar. Carter’s selection comes as a surprise: Her background is not in drug policy, public health, or law enforcement, and she has never served in government.…